Overview

Assessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan Tracer

Status:
Recruiting
Trial end date:
2021-12-12
Target enrollment:
Participant gender:
Summary
This study is a phase I clinical trial aimed to determine the recommended dose of 99mTc-NTP 15-5 to obtain the best tracer joints contrast on images without any toxicity.
Phase:
Early Phase 1
Details
Lead Sponsor:
Centre Jean Perrin